Argent Trust Company’s Quest Diagnostics DGX Stock Holding History

Argent Trust Company’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.6M	Sell	26,106 -249	-0.9%	-$17.4K	0.71%	42
2015 Q2	$1.91M	Buy	26,355 +70	+0.3%	+$5.17K	0.76%	44
2015 Q1	$2.02M	Buy	26,285 +2,300	+10%	+$165K	0.82%	44
2014 Q4	$1.61M	Sell	23,985 -500	-2%	-$31.6K	0.65%	52
2014 Q3	$1.49M	Sell	24,485 -795	-3%	-$49K	0.58%	57
2014 Q2	$1.48M	Sell	25,280 -160	-0.6%	-$9.37K	0.52%	62
2014 Q1	$1.47M	Buy	25,440 +664	+3%	+$35.6K	0.55%	60
2013 Q4	$1.33M	Sell	24,776 -850	-3%	-$50.4K	0.5%	65
2013 Q3	$1.58M	Sell	25,626 -25	-0.1%	-$1.5K	0.67%	50
2013 Q2	$1.55M	Buy	+25,651	New	+$1.53M	0.69%	46

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Argent Trust Company's DGX Position: Q3 2015 in Review

Argent Trust Company reduced its Quest Diagnostics (DGX) stake by 0.94% in Q3 2015, selling an estimated $17.4K and leaving 26,106 shares worth $1.6M. The position accounts for 0.71% of the portfolio, ranked #42.

Argent Trust Company first reported a position in DGX in Q2 2013 and has held it in 10 quarters since. The position peaked at $2.02M in Q1 2015. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

Argent Trust Company held 26,106 shares of Quest Diagnostics worth $1.6M as of Q3 2015.
Argent Trust Company sold 249 Quest Diagnostics shares in Q3 2015, an estimated $17.4K.
Quest Diagnostics made up 0.71% of Argent Trust Company's portfolio in Q3 2015, its #42 holding.
Argent Trust Company first reported a position in Quest Diagnostics in Q2 2013 and has held it in 10 quarters since.
Argent Trust Company's Quest Diagnostics position peaked at $2.02M in Q1 2015.
540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on Argent Trust Company's 13F filing for Q3 2015, filed 13 Nov 2015.